Posts

Showing posts with the label Cost Effectiveness

Healthcare Landscape in Pakistan – Private Sector – Asrar Qureshi’s Blog Post 978

Image
Healthcare Landscape in Pakistan – Private Sector – Asrar Qureshi’s Blog Post 978 Dear Colleagues! This is Asrar Qureshi’s Blog Post 978 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Anna Shvets Credit: Los Muertos Crew Credit: RDNE Stock Project In a study that the Lancet conducted, healthcare in Pakistan currently ranks 154th out of 195 countries in terms of overall performance. This included both public and private healthcare. I would start with the clarification that private healthcare sector, while doing a good job, is not providing world-class treatment as is claimed by them. Private healthcare outperforms their public counterparts, as measured by the overall quality of healthcare and patient satisfaction, latter being trumpeted more. I had quoted earlier also that the business generated by private hospitals is e...

Where is the Patient in Healthcare Landscape?  – Asrar Qureshi’s Blog Post 963

Image
Where is the Patient in Healthcare Landscape?  – Asrar Qureshi’s Blog Post 963 Dear Colleagues! This is Asrar Qureshi’s Blog Post 963 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Azra Tuba Demir Credit: Jonathan Borba Credit: LLos Muertos Crew Credit: Max Mishin Preamble Health and education are important subjects for politics and therefore get new ideas whenever a new government comes in. It is however a pity that previous government initiatives are usually scraped by the new government. Some may be baptized with a new name and launched again. In the education sector, Danish school was the last major initiative in Punjab which, surprisingly, is still running well. Sehat Card was the last major initiative from the PTI government. Present incumbent government has raised questions about it and its fate is still hang...

New Gene Therapy Products – Part 1 – Asrar Qureshi’s Blog Post #746

Image
New Gene Therapy Products – Part 1 – Asrar Qureshi’s Blog Post #746 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #746 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Ivan Samkov Photo Credit: Google Images Gene therapy is among the newest modalities of treatment. It is still an experimental treatment that works by introducing genetic material into a person’s cell to fight or prevent disease. Gene Therapy is presently being tested for several diseases, such as autoimmune disorders, hemophilia, thalassemia, Parkinson’s disease, cancer, diabetes, heart disease, and so on. In this treatment, a gene can be delivered to a cell using a carrier called ‘vector’. Mostly, viruses are used as vectors due to their innate ability ...

Pakistan Pharma Industry SWOT – Part 46 – Asrar Qureshi’s Blog Post #637

Image
Pakistan Pharma Industry SWOT – Part 46 – Asrar Qureshi’s Blog Post #637 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #637 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Opening Note February 2022 marked my completing 47 years of working in Pharma Industry. Allah be praised. I am still working. My journey of near half century is also the journey of Pharma Industry in Pakistan. Great changes have occurred in this time and a lot could be written about it. In my blogs, which were started about four and a half years ago, I have covered several topics related to Pakistan Pharma Industry. This multi-part series is the SWOT – Strengths, Weaknesses, Opportunities, Threats – Analysis of the Pharma Industry and propose strategies. Strategies to ...